🔎 Trials Near Me

Akèy › Skleroz Miltip › New York

Etid klinik pou Skleroz Miltip nan New York

19 etid pou Skleroz Miltip ap chèche patisipan nan sit nan New York.

Vil nan New York

Tèks ofisyèl etid la (Anglè)

Vancomycin Study in Multiple Sclerosis (MS)

  • Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai, New York
Ap rekriteFaz 1
Laj 18 a 50 · Tout sèks · Mizajou Sep 28, 2026 · NCT05539729

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

  • TG Therapeutics Investigational Trial Site, Amherst
  • TG Therapeutics Investigational Trial Site, New York
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06433752

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • NYU Langone Hospital - Long Island, Mineola
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • ak 1 plis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

  • Mt. Sinai, New York
Ap rekriteFaz 1/2
Laj 18 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT07477639

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • Roswell Park Center Institute, Buffalo
  • NYU Langone Health, New York
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

  • TG Therapeutics Investigational Trial Site, New York
  • TG Therapeutics Investigational Trial Site, Rochester
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06680037

An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

  • Research Site, New York
  • Research Site, New York
Ap rekriteFaz 1
Laj 18 a 60 · Tout sèks · Mizajou Aug 25, 2026 · NCT07224373

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

  • Columbia University Irving Medical Center, New York
Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Aug 14, 2026 · NCT07304154

Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

  • Mount Sinai School of Medicine, New York
Ap rekriteFaz 2
Laj 18 a 60 · Tout sèks · Mizajou Jul 17, 2026 · NCT07497399

Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)

  • NYU Langone Health, New York
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Jun 29, 2026 · NCT06901687

Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders

  • Mount Sinai Hospital, New York
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jun 15, 2026 · NCT05982925

Genes and Environment in Multiple Sclerosis

  • Columbia University Irving Center, New York
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou May 14, 2026 · NCT01353547

A Palliative Care Model Impact on Knowledge and Attitudes

  • Judith Jaffe Multiple Sclerosis Center, New York
  • Hunter College, New York
Ap rekrite
Laj 18 a 65 · Tout sèks · Mizajou Apr 22, 2026 · NCT06860932

Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)

  • UBMD Neurolgy, Buffalo
Ap rekriteFaz 2
Laj 55 a 75 · Tout sèks · Mizajou Nov 21, 2025 · NCT06463743

Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?

  • Jacobs School of Medicine and Biomedical Sciences, Neurology, University at Buffalo, Buffalo
Ap rekrite
Laj 18 a 65 · Tout sèks · Mizajou Nov 10, 2025 · NCT07225868

A Study of the MIND Diet for Persons With Multiple Sclerosis

  • Mount Sinai Hospital, New York
Ap rekrite
Laj 18 a 70 · Tout sèks · Mizajou Oct 14, 2025 · NCT06992115

NYSCF Scientific Discovery Biobank

  • New York Stem Cell Foundation Research Institute, New York
Ap rekriteEtid obsèvasyon
30 Days · Tout sèks · Mizajou Mar 3, 2025 · NCT06203106

Eccentric Exercise and Fatigue in Multiple Sclerosis

  • Hunter College, Physical Therapy Department, City University of New York, New York
Ap rekriteEtid obsèvasyon
Laj 18 a 75 · Tout sèks · Mizajou Jul 17, 2024 · NCT06505421

Effect of Cooling on Balance Performance in Multiple Sclerosis

  • Hunter College, Physical Therapy Department, City University of New York, New York
Ap rekriteEtid obsèvasyon
Laj 18 a 75 · Tout sèks · Mizajou Nov 15, 2023 · NCT06094855

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.